Vikas Sinha

Companies

• Scholar Rock Holding CorpChief financial officer Apr 29, 2025 to now¹
• Verona PharmaBoard member Jan 4, 2021 to now²
• Kalaris Therapeutics, Inc.Board member Jul 30, 2020 to Feb 24, 2025³
• Kalaris Therapeutics, Inc.Officer Jul 30, 2020 to Feb 24, 2025³
• BCLS Acquisition Corp.Board member Oct 22, 2020 to Oct 22, 2020⁴
• Alexion PharmaceuticalsChief financial officer Jan 10, 2006 to Aug 10, 2016⁵
• Alexion PharmaceuticalsBoard member Jan 17, 2007 to Sep 25, 2007⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SRScholar Rock Holding Corp SRRK619,856 shares⁷$25.3M at $40.78Apr 16, 2026
• KTKalaris Therapeutics, Inc. KLRS774,118 shares⁸$1.7M at $2.19Feb 24, 2025
• Verona Pharma VRP0 shares⁹Oct 7, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 16, 2026Sold 10,410 shares at $49.57 of Scholar Rock Holding Corp⁷
• Feb 9, 2026Granted 47,021 shares of Scholar Rock Holding Corp¹⁰
• Jan 13, 2026Sold 16,755 shares at $42.70 of Scholar Rock Holding Corp¹¹
• Oct 7, 2025Returned to company 72,000 shares of Verona Pharma⁹
• Oct 7, 2025Exercised options 72,000 shares of Verona Pharma⁹
• Oct 7, 2025Returned to company 94,112 shares of Verona Pharma⁹
• Aug 1, 2025Sold 4,328 shares at $13.14 of Verona Pharma¹²
• Aug 1, 2025Exercised options 24,000 shares of Verona Pharma¹²
• May 20, 2025Sold 160,000 shares at $9.39 of Verona Pharma¹³
• May 20, 2025Exercised options 160,000 shares at $0.50 of Verona Pharma¹³
• Apr 29, 2025Sold 39,616 shares at $8.92 of Verona Pharma¹⁴
• Apr 29, 2025Sold 4,952 shares at $8.92 of Verona Pharma¹⁵
• Apr 29, 2025Exercised options 39,616 shares at $0.50 of Verona Pharma¹⁴
• Apr 29, 2025Exercised options 4,952 shares at $0.50 of Verona Pharma¹⁵
• Apr 29, 2025Sold 120,384 shares at $8.92 of Verona Pharma¹⁴
• Apr 29, 2025Sold 15,048 shares at $8.92 of Verona Pharma¹⁵
• Apr 29, 2025Exercised options 120,384 shares at $1.70 of Verona Pharma¹⁴
• Apr 29, 2025Exercised options 15,048 shares at $1.70 of Verona Pharma¹⁵
• Apr 27, 2025Granted 500,000 shares of Scholar Rock Holding Corp¹⁶
• Apr 27, 2025Granted 100,000 shares of Scholar Rock Holding Corp¹⁶
• Feb 21, 2025Sold 303 shares at $10.08 of Kalaris Therapeutics, Inc.⁸
• Jan 23, 2025Sold 13 shares at $9.94 of Kalaris Therapeutics, Inc.¹⁷
• Jan 23, 2025Sold 116 shares at $9.45 of Kalaris Therapeutics, Inc.¹⁷
• Jan 10, 2025Sold 979 shares at $0.44 of Kalaris Therapeutics, Inc.¹⁸
• Nov 19, 2024Sold 3,186 shares at $0.55 of Kalaris Therapeutics, Inc.¹⁹